These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aldosterone antagonists in heart failure. Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084 [TBL] [Abstract][Full Text] [Related]
3. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction]. MMW Fortschr Med; 2003 Oct; 145(44):42-3. PubMed ID: 14655506 [No Abstract] [Full Text] [Related]
4. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767 [TBL] [Abstract][Full Text] [Related]
5. [Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects]. Yamamoto T Nihon Rinsho; 2007 May; 65 Suppl 5():102-6. PubMed ID: 17571373 [No Abstract] [Full Text] [Related]
6. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms]. MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226 [No Abstract] [Full Text] [Related]
7. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Pitt B; Williams G; Remme W; Martinez F; Lopez-Sendon J; Zannad F; Neaton J; Roniker B; Hurley S; Burns D; Bittman R; Kleiman J Cardiovasc Drugs Ther; 2001 Jan; 15(1):79-87. PubMed ID: 11504167 [No Abstract] [Full Text] [Related]
8. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers. Aaronson K Health News; 2003 May; 9(5):4. PubMed ID: 12739453 [No Abstract] [Full Text] [Related]
11. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure. Barnes BJ; Howard PA Ann Pharmacother; 2005 Jan; 39(1):68-76. PubMed ID: 15590870 [TBL] [Abstract][Full Text] [Related]
13. Adherence to aldosterone-blocking agents in patients with heart failure. Margolis J; Gerber RA; Roberts C; Gheorghiade M Am J Ther; 2010; 17(5):446-54. PubMed ID: 20844344 [TBL] [Abstract][Full Text] [Related]
14. Hyperkalaemia in the age of aldosterone antagonism. Chapagain A; Ashman N QJM; 2012 Nov; 105(11):1049-57. PubMed ID: 22723454 [TBL] [Abstract][Full Text] [Related]